Is N-acetylcysteine (NAC) safe for a 5-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is NAC Safe for a 5-Year-Old?

Yes, N-acetylcysteine (NAC) is generally safe for a 5-year-old child when used appropriately, with well-established safety profiles across multiple indications, though the specific indication, route of administration, and dosing must be carefully considered. 1, 2

Safety Profile by Indication

Acetaminophen Overdose (Established Use)

  • NAC is listed on the WHO Model List of Essential Medicines as an antidote for poisoning and has been used safely as a drug since the 1960s 1
  • This represents the most well-established pediatric use with decades of safety data 2

Acute Liver Failure (Non-Acetaminophen)

  • A large placebo-controlled trial (PALF Study) in 184 children demonstrated that NAC was safe but NOT effective for non-acetaminophen acute liver failure in children 3
  • The trial used continuous IV infusion of 150 mg/kg/day for up to 7 days without significant safety concerns 3
  • An earlier retrospective study of 111 children receiving NAC at 100 mg/kg/24 hours showed complications in only 8 (10.8%) children: rash (3), arrhythmia (3), dizziness and peripheral edema (1), with only one child requiring discontinuation due to bronchospasm 4
  • Critical caveat: While safe, NAC actually decreased transplant-free survival in children under 2 years old with non-acetaminophen liver failure, particularly those with low-grade encephalopathy 3

Respiratory/Mucolytic Use (NOT Recommended)

  • The European Respiratory Society explicitly recommends AGAINST nebulized NAC in children due to lack of efficacy and risk of bronchoconstriction 5
  • Bronchoconstriction is a documented adverse effect that makes nebulized NAC potentially harmful rather than beneficial in pediatric respiratory conditions 5
  • The Cystic Fibrosis Foundation concluded that evidence is insufficient to recommend for or against chronic use of inhaled or oral NAC in CF patients 6 years and older, with no clinical benefit demonstrated and zero net benefit 6

Parenteral Nutrition Support

  • NAC at 20-50 mg/kg/day has been used to increase blood glutathione levels in pediatric parenteral nutrition 7
  • This represents a safe application when glutathione precursor supplementation is needed 7

Route-Specific Safety Considerations

Intravenous Administration

  • Most safety data exists for IV NAC, particularly in acetaminophen overdose and acute liver failure 4, 3
  • Adverse effects are uncommon and dose-dependent, including rash, arrhythmia, and rare anaphylactoid reactions 4, 2

Oral Administration

  • NAC is available over-the-counter and has an established tolerance and safety profile 1, 8
  • Toxicity is uncommon and dependent on route and high dosages 2

Nebulized/Inhaled Administration

  • Should be avoided in children due to bronchoconstriction risk and lack of efficacy 5
  • Do not use in children with reactive airway disease 5

Age-Specific Considerations for a 5-Year-Old

  • The PALF trial included children from birth through 17 years, demonstrating safety across pediatric age ranges 3
  • The Cystic Fibrosis Foundation guidelines specifically address children 6 years and older, placing a 5-year-old just below this threshold but within the general pediatric safety data 6
  • Retrospective data includes children as young as 0.003 years (approximately 1 day old) receiving NAC safely 4

Common Pitfalls to Avoid

  • Do not assume that because NAC is safe for acetaminophen poisoning, it is appropriate for all pediatric indications—the risk-benefit profile differs dramatically by indication 5
  • Never use nebulized NAC as a mucolytic in children with reactive airway disease due to bronchoconstriction risk 5
  • Do not use NAC for non-acetaminophen acute liver failure in children under 2 years old, as it may worsen outcomes 3
  • Do not confuse glutathione with glutamine—these are different compounds with different indications 7
  • Avoid extrapolating adult mucolytic dosing to children without pediatric-specific evidence 5

Clinical Decision Algorithm

For a 5-year-old, NAC safety depends on:

  1. Acetaminophen overdose? → Yes, use NAC (standard antidote) 1, 2

  2. Non-acetaminophen acute liver failure? → Safe but NOT effective; consider only if no other options and child is >2 years old 3

  3. Respiratory/mucolytic indication? → Do NOT use nebulized NAC; no evidence of benefit and risk of bronchoconstriction 5

  4. Parenteral nutrition support? → Safe at 20-50 mg/kg/day as glutathione precursor 7

  5. Psychiatric or other investigational uses? → Safety profile established but efficacy data limited in pediatrics 8

References

Research

Medical and Dietary Uses of N-Acetylcysteine.

Antioxidants (Basel, Switzerland), 2019

Research

N-Acetylcysteine (NAC): Impacts on Human Health.

Antioxidants (Basel, Switzerland), 2021

Research

Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008

Guideline

N-Acetylcysteine Use in Pediatric Respiratory Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Glutathione Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.